Sukhmani (suki) K. Padda MD

Dr. Padda is the Director of Thoracic Medical Oncology at Cedars-Sinai Medical Center. She completed an internal medicine residency and hematology/oncology fellowship at Stanford University in 2014. After serving as faculty at Stanford University, in 2021, she joined the Cedars-Sinai Division of Medical Oncology, Department of Medicine. In collaboration with multi-disciplinary clinical experts and scientists, Dr. Padda's goals are focused on expanding clinical trials and translational research in thoracic oncology. The ultimate goal of this research is to improve the outcomes of patients with thoracic malignancies. She works with thoracic oncology experts around the country, leading and participating in clinical trials through the National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP) Cooperative Groups (e.g., ECOG, SWOG). She chairs the International Association for the Study of Lung Cancer (IASLC) Career Development/Fellowship Committee, which provides funding to early-career lung cancer researchers around the world.

Dr. Padda's research focus is on the clinical investigation of novel targeted therapeutics in genomic subsets of non-small cell lung cancer (e.g., EGFR, KRAS) and in the clinical investigation of novel immunotherapeutics across thoracic malignancies. She also has clinical and research expertise in rare thoracic tumors, including lung neuroendocrine tumors and thymic malignancies, and is a member of the North American Neuroendocrine Tumor Society (NANETS) and International Thymic Malignancy Interest Group (ITMIG).